NCT05619328Phase 3Completed

A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.

Study sponsor: Procter and Gamble

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-11-02Actual
Enrollment · participants323Actual
Source updated2023-11-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview